NEUROPORT array FDA cleared industry standard.

The industry standard for clinical electrophysiology.

The Neuroport Array is FDA-cleared for up to 30 days of monitoring and recording of brain electrical activity with IDE/IRB approval. With IDE/IRB approval, the Neuroport array may be implanted for more than 30 days of monitoring/recording. Blackrock has assisted many clinical users through this approval process—for more information, please contact us.

The Neuroport Array has been at the foundation of many recent breakthroughs in the field of brain-computer interface (BCI) research and has been a part of many groundbreaking clinical studies. Take a look at our News section to find out about the details. Examples of Neuroport Array users in the clinical space include:

Key advantages

  • Great for multi-channel, high density neural recordings. Device provides a reliable means to sample large numbers of neurons at regular spacing across the cortical surface
  • The Neuroport array has been successfully employed in dozens of studies, providing sensitive and stable recordings.
  • For one example of how the arrays have advanced clinical science, visit the BrainGate site
  • High-quality neural recordings accessible immediately after implantation
  • Floating neural interface
  • Sterilizable
  • Excellent stability in acute and chronic applications
  • Microstimulation-capable

Neuroport Array Specifications

Channel count 96
Electrode site metal options Pt or IrOx
Reference and ground 2 reference wires
Insulation Parylene-C
Standard electrode length 1 – 1.5 mm
Standard electrode pitch 400  μm
Multiport options No
Wire bundle material 99Au/1Pd, Terester, and Nusil MED-4211
Wire bundle length 13 cm
Wire bundle width 0.55mm to 0.85mm


Share this: